D-chiro-inositol-its functional role in insulin action and its deficit in insulin resistance

International Journal of Experimental Diabetes Research

Volumn 3, Issue 1, 2002, Pages 47-60

  Larner, Joseph ^a  

^a Insmed Incorporated   (United States)

Author keywords

D chiro inositol; Diabetes; Epimerase; GK rat; Glucose disposal; Insulin resistance; Insulin sensitizer; Myo inositol; Phosphoprotein phosphatase

Indexed keywords

GLUCOSE; GLYCOGEN SYNTHASE; INOSITOL; INSULIN; PYRUVATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CONTROLLED STUDY; HORMONE ACTION; HUMAN; IN VIVO STUDY; INSULIN DEFICIENCY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MEDIATOR; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RAT; RHESUS MONKEY; URINARY EXCRETION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; GLYCOGEN SYNTHASE; INOSITOL; INSULIN; INSULIN RESISTANCE; KINETICS; MACACA MULATTA; OBESITY; RATS; STEREOISOMERISM;

EID: 0036401974     PISSN: 15604284     EISSN: None     Source Type: Journal    
DOI: 10.1080/15604280212528     Document Type: Article

References (55)

1. Daughaday, W.H., Larner, J, and Hartnett, C. (1955) The synthesis of mositol in the immature rat and chick embryo. J. Biol. Chem. 212, 869-875.
2. Dean-Johnson, M., and Henry, S.A. (1989) Biosynthesis of inositol in yeast. Primary structure of myo-inositol-1-phosphate synthase (EC5.5.1.4) and functional analysis of its structural gene, the IN01 locus. J. Biol. Chem. 264, 1274-1283.
3. Anderson, A.B. (1953) Pinitol from sugar pine stump wood. Ind. and Eng. Chem. 45, 593-596.
4. Schmatz, D.M., Arison, B.H., Dashkevicz, M.P., Liesch, J.M., Turner, M.J. (1988) Identification and possible role of D-mannitol and 2-0-methyl-chiro-inositol (quebrachitol) in Eimeria tenella. Molec. and Biochem. Parasitol. 29, 29-36.
5. Bruzik, K.S., Hakeem, A.A., and Tsai, M.D. (1994) Are D- and L- chiro-phosphoinositides substrates of phosphoinositol-specific phospholipase. C. Biochem. 33, 8367-8374.
6. Kennington, A.S. (1990) Insulin mediators and their inositol components. Ph.D. Thesis, University of Virginia.
7. Williamson, J.R., Chang, K., Rowold, E., Marvel, J., Tomlinson, M., Sherman, W.R. et al. (1986) Diabetes-induced increases in vascular permeability and changes in granulation tissue levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinil. Metabolism 35: (Suppl 1), 41-45.
8. Niwa, T., Yamamoto, N., Maeda, K., Yamada, K. (1983) Gas chromatographic-mass spectro-metric analysis of polyols in urine and serum of uremic patients. Identification of new deoxyalditols and inositol isomers. J. Chrom. 277, 25-39.
9. Mato, J.M., Kelly, K.L., Abler, A., Jarett, L., Corkey, B.E., Cashel, J.A. et al. (1987) Partial structure of an insulin-sensitive glycophospholipid. Biochem Biophys. Res. Commun. 146, 764-772.
10. Larner, J., Huang, L.C., Schwartz, C.F.W., Oswald, A.S., Shen, T.Y., Kinter, M., et al. (1988) Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphatase contains galactosamine and D-chiro-inositol. Biochem. Biophys. Res. Commun. 151, 1416-1426.
11. Kennington, A.S., Hill, C.R., Craig, J., Bogardus, C., Raz, I., Ortmeyer, H.K., et al. (1990) Low urinary chiro-inositol excretion in noninsulin-dependent diabetes mellitus. N. Eng. J. Med. 323, 373-378.
12. Ostlund, R.E., McGill, J.B., Herskowitz, I., Kipnis, D.M., Santiago, J.V., Sherman, W.R. (1993) D-chiro-inositol metabolism in diabetes mellitus. Proc. Natl. Acad. Sci. USA 90, 9988-9992.
13. Daughaday, W.H., and Larner, J. (1954) The renal excretion of inositol in normal and diabetic human beings. J. Clin. Invest. 33, 326-332.
14. Suzuki, S., Taneda, Y., Hirai, S., Abe, S., Sasaki, A., Suzuki, K., and Toyota, T. (1991) Molecular mechanism of insulin resistance in spontaneous diabetic GK (Goto-Kakizaki) rats. In New Directions in Research and Clinical Works for Obesity and Diabetes Mellitus. Angel. A., Hotta, N. eds. Elsevier, 197-203.
15. Ortmeyer, H.K., Bodkin, N.L., Lilley, K., Larner, J. and Hansen, B.C. (1993) Chiro-inositol deficiency and insulin resistance. I. Urinary excretion rate of chiro-inositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys. Endocrinology 132, 640-645.
16. Suzuki, S., Kawasaki, H., Satoh, Y., Ohtomo, M., Hirai, M., Hirai, A., Hirai, S., Onoda, M., Matsumoto, M., Hinokio, Y., Akai, H., Craig, J., Larner, J., and Toyota, T. (1994) Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type 11 diabetes. Diabetes Care 17, 1465-1468.
17. Larner, J. and Craig, J.W. (1996) Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance. Diabetes Care 19, (1) 76-78.
18. Wahl, H.G., Grener, B., Werner, R., Schmuelling, R.M. (1998) Urinary myo-/chiro-inositol ratio is increased in NIDDM patients and in non-diabetic first degree relatives. Diabetes 47, A429 (Abstract).
19. Asplin, I., Galasko, G., and Larner, J. (1993) Chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol and the myo-inositol containing insulin mediators isolated from urine, hemodialysate and muscle of control and type II diabetic subjects. Proc. Natl. Acad. Sci. USA 90, 5924-5928.
20. Huang, L.C., Fonteles, M.C., Houston, D.B., Zhang, C., and Larner, J. (1993) Chiro-inositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin diabetic rats in vivo. Endocrinology 132, 652-657.
21. Fonteles, M.C., Huang, L.C., and Larner, J. (1996) Infusion of pH 2.0 D-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycemia. Diabetologia 39, 731-734.
22. Egan, J.M., Asplin, C.M., Evans, W.S., Huang, L.C., and Larner, J. (1991) The effect of a chiro-inositol containing insulin mediator on insulin release in rats (Abstract). Diabetes 40, (Suppl. 1) 187A.
23. Farese, R.V., Standaert, M.L., Yamada, K., Huang, L.C., Zhang, C., Cooper, D.R., Wang, Z., Tang, Y., Suzuki, S., Toyota, T. and Larner, J. (1994) Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats. Proc. Natl. Acad. Sci. USA 91, 11040-11044.
24. Schofield, L. and Hackett, F. (1993) Signal transduction host cells by a glycosyl phosphatidyl inositol toxin of malaria parasites. J. Exp. Med. 177, 145-153.
25. 3H1 cells. Proc. Natl. Acad. Sci. USA 87, 1476-1480.
26. Romero, G., Garmey, J.C., and Veldhuis, J. (1993) The involvement of inositol phosphoglycan mediators in the modulation of steroidogenesis by insulin-like growth factor-1. Endocrinology 132, 1561-1568.
27. Variela, I., Alvarez, J.F., Clemente, R., Ruiz-Albusac, J.M., and Mato, J.M. (1990) Asymmetric distribution of the phosphatidylinositol-linked phospho-oligosaccharide that mimics insulin action in the plasma membranes. Eur. J. Biochem. 188, 213-218.
28. Alvarez, J.F., Sanchez-Arias, J.A., Guadano, A., Estevez, F., Varela, L, Feliu, J.E., and Mato, J.M. (1991) Transport in isolated rat hepatocytes of the phospho-oligosaccharide that mimics insulin action. Effects of adrenalectomy and glucocorticoid treatment. Biochem. J. 274, 369-371.
29. Ortmeyer, H.K., Huang, L.C., Zhang, L., Hansen, B.C., and Larner, J. (1993) Chiro-inositol deficiency and insulin resistance. II. Acute effects of D-chiro-inositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistant rhesus monkeys. Endocrinology 132, 646-651.
30. Ortmeyer, H.K., Bodkin, N.L., Hansen, B.C., and Larner, J. (1995) In vivo D-chiro-inositol activates skeletal muscle glycogen synthase and inactivates glycogen phosphorylase in Rhesus monkeys. J. Nutr. Biochem. 6, 499-503.
31. Pak, Y. and Larner, J. (1992) Identification and characterization of chiro-inositol-containing phospholipids from bovine liver. Biochem. Biophys. Res. Commun. 184, 1042-1047.
32. 3H]inositol into phospholipid in the Goto-Kakizaki (G.K.) Rat. Mol. Cells 8, (3) 301-309.
33. Yoshino, Y., Takeda, N., Sugimoto, M., Nakashima, K., Okumura, S., Hattori, J., Sasaki, A., Kawachi, S., Takami, K., Takami, R., and Yasuda, K. (1999) Differential effects of troglitazone and D-chiro-inositol on glucosamine-induced insulin resistance in rats. Metabolism 48, 1418-1423.
34. Ortmeyer, H.K. (1996) Dietary myo-inositol results in lower urine glucose and in lower post prandial plasma glucose in obese insulin resistant Rhesus monkeys. Obesity Res. 4, 569-575.
35. 3H]inositol. J. Biol. Chem. 271, 10073-10078.
36. Larner, J., Huang, L.C., Suzuki, S., Tang, G., Zhang, C., Schwartz, C.F.W., Romero, G., Luttrell, L. and Kennington, A.S. (1989) Insulin mediators and the control of pyruvate dehydrogenase. Ann. N.Y. Acad. Sci. 573, 297-305.
37. Abe, S., Huang, L.C., and Larner, J. (1996) Dephosphorylation of PDH by phosphoprotein phosphatases and its allosteric regulation by inositol glycans. In alpha-keto-acid dehydrogenase complexes. Patel, M.S., Roche, T.E., Harris, R.A. Eds. Basel, Birkhauser, 187-195.
38. Das, A.K., Helps, N.R., Cohen, P.T.W, and Barford, D. (1996) Crystal structure of the protein serine/threonine phosphatase 2C at 2.0 Å resolution. Embo J. 15, 6798-6809.
39. Denton, R.M., Midgley, P.J.W., Rutter, G.A., Thomas, A.P., and McCormack, J.G. (1989) Studies into the mechanism whereby insulin activates pyruvate dehydrogenase complex in adipose tissue. Ann N.Y. Acad. Sci. 573, 285-296.
40. Ortmeyer, H.K. (1998) Insulin increases liver protein phosphatase 1 and protein phosphatase 2C activates in lean, young adult Rhesus monkeys. Horm. Metab. Res. 30, 705-710.
41. Brady, M.J., Bourbonais, F.J., and Saltiel, A.R. (1998) The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells. J. Biol. Chem. 273, 14063-14066.
42. Ragolia, L., and Begum, N. (1998) Protein phosphatase 1 and insulin action. Mol. Cell. Biochem. 182, 49-58.
43. Huang, L.C., Heimark, D., Linko, J., Nolan, R., and Larner, J. (1999) A model phosphatase 2C phosphatase 1 activation cascade via dual control of inhibitor 1 (INH-1) and DARPP-32 dephosphorylation by two inositol glycan putative insulin mediators from beef liver. Biochem. Biophys. Res. Commun. 255, 150-156.
44. Foulkes, J.G., Cohen, P., Strada, S.J., Everson, W.V., and Jefferson, L.S. (1982) Antagonistic effects of insulin and β-adrenergic agonists on the activity of protein phosphatase inhibitor-1 in skeletal muscle of the perfused rat hemicorpus. J. Biol. Chem. 257, 12493-12496.
45. Malchoff, C.D., Huang, L.C., Gillespie, N., Villar-Palasi, C., Schwarz, C.F.W., Cheng, K., Hewlett, E.L., and Larner, J. (1987) A putative mediator of insulin action which inhibits adenylate cyclase and adenosine 3', 5'-monophosphate-dependent protein kinase: partial purification from rat liver, site and kinetic mechanism of action. Endocrinology 120, 1327-1337.
46. Wober, G., and Hoffman-Ostenhof, O. (1969) Untersuchungen uber die Biosynthese der Cyclite, 22 Mitt.: Cyclite in Chlorella fusca. Monatsh. Chem. 100, 369-375.
47. + epimerase and inosose: NAD(P)H reductase from the body fat of American cockroach. Periplaneta Americana L. Biochemistry 12, 4705-4712.
48. Hipps, P.P., Ackermann, K.E. and Sherman, W.R. (1982) Inositol epimerase-Inosose reductase from bovine brain. Meth. In Enzymol. 89, 593-598.
49. 3H]chiro-inositol in rat tissues. J. Biol. Chem. 267, 16904-16910.
50. Pak, Y., Paule, C.R., Bao, Y-D., Huang, L.C., and Larner, J. (1993) Insulin stimulates the biosynthesis of chiro-inositol containing phospholipids in a rat fibroblast line expressing the human insulin receptor. Proc. Natl. Acad, Sci. USA 90, 7759-7763.
51. Larner, J. and Huang, L.C. (1999) Identification of a novel inositol glycan signaling pathway with significant therapeutic relevance to insulin resistance: an insulin signaling model using both tyrosine kinase and G proteins. Diabetes Rev. 7, 217-231.
52. Field, M.C. (1997) Is there evidence for phospho-oligosaccharides as insulin mediators. Glycobiology 7, 161-168.
53. Jones, D.R. and Varela-Nieto, I. (1999) Diabetes and the role of inositol-containing lipids in insulin signaling. Molec. Med. 5, 505-514.
54. Varela-Nieto, I., Leon, Y. and Caro, H.N. (1996) Cell signaling by inositol phosphoglycans from different species. Comp. Biochem. Physiol. 115B, 223-241.
55. Hansen, B.C. and Ortmeyer, H.K. (1996) Inositols potential roles in insulin action and in diabetes: Evidence from insulin resistant nonhuman primates. Lessons from Animal Diabetes VI, E. Shafrir Ed. Birkhuser, Boston 333-348.